Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial

[1]  S. Potkin,et al.  A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization , 2006, Schizophrenia Research.

[2]  T. Stroup,et al.  Risperidone versus olanzapine for schizophrenia. , 2006, The Cochrane database of systematic reviews.

[3]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[4]  W. Fleischhacker,et al.  Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. , 2004, The Journal of clinical psychiatry.

[5]  M. Ritsner,et al.  Subjective Response to Antipsychotics of Schizophrenia Patients Treated in Routine Clinical Practice: A Naturalistic Comparative Study , 2004, Journal of clinical psychopharmacology.

[6]  A. Awad,et al.  New Antipsychotics, Compliance, Quality of Life, and Subjective Tolerability—Are Patients Better Off? , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[7]  Bruno Falissard,et al.  Focused Principal Component Analysis: Looking at a Correlation Matrix with a Particular Interest in a Given Variable , 1999 .

[8]  J. Sitzia.  How valid and reliable are patient satisfaction data? An analysis of 195 studies. , 1999, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[9]  B. Druss,et al.  Patient satisfaction and administrative measures as indicators of the quality of mental health care. , 1999, Psychiatric services.

[10]  T. Burns,et al.  Satisfaction with in-patient psychiatric services , 1999, British Journal of Psychiatry.

[11]  S. Marder,et al.  The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. , 1997, The Journal of clinical psychiatry.

[12]  P. Bech,et al.  Satisfaction with care reported by psychiatric inpatients Relationship to diagnosis and medical treatment , 1993, Acta psychiatrica Scandinavica.

[13]  T. Hogan,et al.  Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures , 1992, Psychological Medicine.

[14]  T. Hogan,et al.  A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity , 1983, Psychological Medicine.

[15]  R. A. May,et al.  Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point. , 1978, Archives of general psychiatry.

[16]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[17]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[18]  M. Atkinson,et al.  Health and Quality of Life Outcomes , 2004 .

[19]  J. Lieberman,et al.  The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. , 2003, Schizophrenia bulletin.

[20]  J. Rabinowitz,et al.  Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study. , 2001, Schizophrenia bulletin.

[21]  A. Kalali,et al.  Patient satisfaction with, and acceptability of, atypical antipsychotics. , 1999, Current medical research and opinion.

[22]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.